activesellsec_filings

LULU 10-Q report for 2025-08-03

lululemon filed its Form 10-Q for the quarter ended August 3, 2025. The filing includes unaudited interim consolidated financial statements (balance sheet, statements of operations, stockholders' equity, cash flows), an index to notes, MD&A, market-risk disclosures, and store counts by region. Key metrics include quarterly net revenue of $2,525,219 (thousands), quarterly net income of $370,905 (thousands), cash and cash equivalents of $1,155,794 (thousands) at period end, and inventories of $1,722,570 (thousands).

Confidence
60 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

LULU — lululemon athletica inc. (Nasdaq: LULU). Filing confirms shares outstanding, exchangeable/special voting share counts and provides detailed interim financials and disclosures.

LULUsellopen

lululemon athletica inc. (LULU) Form 10‑Q for quarter ended August 3, 2025 — includes interim consolidated balance sheet, statements of operations, cash flows, and notes. Quarter net revenue $2,525,219; quarter net income $370,905; cash and cash equivalents at period end $1,155,794; inventories $1,722,570 (all amounts in thousands). 113,468,082 shares outstanding as of August 29, 2025; 5,115,961 exchangeable shares and 5,115,961 special voting shares outstanding.

Confidence: 60 / 100Start: $206.09Latest: $125.39Return: 39.16%

Source: lululemon Form 10-Q (quarter ended August 3, 2025). The filing provides: consolidated balance sheet (total assets $7,523,439; cash and cash equivalents $1,155,794; inventories $1,722,570), consolidated statements of operations (quarter net revenue $2,525,219; cost of goods sold $1,048,017; gross profit $1,477,202; net income $370,905), consolidated statements of cash flows (two quarters net income $685,477; net cash provided by operating activities $209,722 for the two quarters; cash decreased by $828,542 during the two-quarter period), share counts and capital‑management activity (repurchases: $715,672 for the two quarters). The filing also includes MD&A, market-risk disclosures (currency hedging details), store counts by region (784 company-operated stores as of August 3, 2025), and an index to notes. The document is an authoritative company disclosure for the stated period and should be used to validate balance-sheet, P&L, cash-flow and capital‑structure facts when forming trading views.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

Primary source: lululemon athletica inc. Form 10-Q for the quarter ended August 3, 2025. The report contains consolidated balance sheets, statements of operations and comprehensive income, statements of stockholders' equity, statements of cash flows, and notes to the unaudited interim consolidated financial statements.

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026 contains identifiers and security descriptions (including warrants) but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Analysis derived from the company's Form 10-Q filing; no external analyst commentary included.

Unlock full thesis monitoring

Use the 10-Q to verify recent operating results, liquidity, inventory build, repurchase activity, and regional store counts. For trade decisions, integrate these reported figures with forward-looking revenue/expense drivers and company guidance (if any) before acting.